TMCnet News

VoxNeuro Names Doug Watt as Chief Revenue Officer
[January 11, 2021]

VoxNeuro Names Doug Watt as Chief Revenue Officer

VoxNeuro, creators of a breakthrough neurotechnology that precisely measures brain health using biomarkers to inform treatment, today named Doug Watt as Chief Revenue Officer. Watt has spent the majority of his career in the Consulting and Software world, with the last 20 years focused on the Healthcare space. Watt is coming to VoxNeuro from Deloitte (News - Alert), where as a Senior Advisor to the Digital Health team for the last year, he has been leading large programs with the Ontario Ministry of Health, Alberta Health and BC Ministry of Health.

This press release features multimedia. View the full release here:

VoxNeuro Names Doug Watt as Chief Revenue Officer (Photo: Business Wire)

VoxNeuro Names Doug Watt as Chief Revenue Officer (Photo: Business Wire)

"Doug's extensive experience in healthcare innovation and business optimization is exactly what we were looking for when we began our search for our Chief Revenue Officer. We look forward to working with Doug to accelerate and elevate VoxNeuro's sales, marketing and customer engagement to drive VoxNeuro's national and international expansion strategy on the back of a strong 2020," Connolly remarked.

Prior to joining Deloitte, Watt spent 6.5 years with eHealth Ontario. He was the Senior Vice President overseeing the Product Management and Account Management teams that were responsible for the delivery and oversight of the Agency's Digital Health and Clinical Data solutions, and e worked with a number of other senior healthcare leaders across Ontario. Watt also held a number of executive positions with Nightingale Informatix over the prior seven years, leading the adoption of innovative technologies at healthcare organizations and physicians' practices.

His efforts in the healthcare world have been primarily selling, building and delivering innovative technology solutions to support the clinical needs of providers and patients, while always focusing on building and growing strong relationships.

"I am so pumped to be joining the team at VoxNeuro. From the first time we met, I have been extremely impressed with the energy, focus and commitment of the entire team," said Doug Watt. "One of the unique things about working in the healthcare world is that we all have a personal story about why we want to make a difference. The groundbreaking work that Voxneuro is doing is going to be my chance to do just that in helping support improved brain health."

About VoxNeuro

VoxNeuro's Cognitive Health Assessments™ measure brain biomarkers to show healthcare providers how the brain is performing in core cognitive functions: attention, concentration, information processing and memory. Armed with this precise data, healthcare providers can rapidly identify issues with cognitive function, remove the need for expensive and time-consuming trial-and-error approaches to cognitive rehabilitation, and track patient progress.

VoxNeuro was founded on the world-renowned research of VoxNeuro's Chief Science Officer, Dr. John F. Connolly. VoxNeuro is headquartered at McMaster Innovation Park in Hamilton, ON (News - Alert), Canada.

The Government of Canada's Trade Commissioner Service selected VoxNeuro as 1 of 11 emerging growth Canadian Life Sciences companies to participate in the Canadian Technology Accelerators' inaugural bi-coastal program led by the Consulates General of Canada in New York and San Francisco. The program, which concluded in November 2020, was dedicated to the development of high-potential, early-stage digital health start-ups into the San Francisco and New York healthcare ecosystems, priming VoxNeuro's US market entry in 2021.

Cognitive Health Assessments™ are available through VoxNeuro's clinical network. To learn more, follow VoxNeuro on LinkedIn, Twitter, Instagram, Facebook and YouTube.

[ Back To's Homepage ]